
FDA Announces Two New Appointments
Dr. Arzu Selen joins FDA's Office of New Drug Quality Assessment (Rockville, MD, www.fda.gov/cder) as the associate director for biopharmaceutics.
Dr. Arzu Selen joins FDA’s Office of New Drug Quality Assessment (Rockville, MD,
Dr. Julie Beitz has been appointed as the director for the Office of Drug Evaluation III (Rockville, MD,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.